|
The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: ---------- Sareum Holdings PLC - Cambridge, England-based pharmaceutical company - Reports pretax loss of £3.1 million for the year ended June 30, against the prior year’s £4.6 million loss. Company was non-revenue generating in both financial years. Cash balance is £3.5 million as of June 30, up from £1.5 million one year prior. Going forward, Sareum says it expects continued progress in financial 2026, including advancing its portfolio ‘through targeted business development and partnerships’. Says it is preparing for the start of SDC-1801 phase 2 patient trials, and notes that it has raised £4.5 million in funds supporting the further development of SDC-1801. ‘With strengthened intellectual property, a healthy balance sheet, prudent financial management and clear milestones ahead, the company is confident of delivering further progress in the year to come,’ Sareum says. ---------- KCR Residential REIT PLC - Surrey, England-based real estate investment trust focused on rented residential property - Reports 5% increase in revenue for the year ended June 30, to £1.9 million from £1.8 million the previous year. Company swings to pretax profit of £327,641, from a £1.2 million loss. ‘The rental market remains tight and we reasonably expect rents to continue to increase over the current financial year reflecting restricted supply and underlying cost pressure for landlords more generally,’ Chair James Thornton says. Still, KCR says that portfolio-level occupancy has remained strong over the financial year, with rental increases continuing at renewals and re-lettings. Adminstrative expenses have increased 2.7% to £1.4 million from £1.3 million. ‘Costs continued to be tightly controlled and whilst the current underlying inflationary environment continues to present challenges, a number of areas for cost savings have been identified and implementation commenced,’ KCR adds. Says it continues to progress towards becoming cashflow positive and creating a stable and scalable platform, adding: ‘We look forward to delivering further improved performance from the existing portfolio over the course of the 2026 financial year.’ ---------- Distil PLC - London-based owner of premium alcoholic drinks brands such as RedLeg Spiced Rum, Blackwoods Gin and Gem Diva - Reports results for the six months ended September 30. Revenue decreases 20% to £313,000 from £393,000 the year before. Pretax loss narrows to £510,000 from £555,000. Total administrative expenses have decreased to £722,000 from £780,000, including advertising and promotional costs decreasing to £216,000 from £239,000. ‘The first six months of the financial year has presented ongoing challenges to the business and to the wider spirits industry as we continue to battle macro-economic conditions imposed by continued rises in inflation,’ comments Executive Chair Don Goulding. He adds however: ‘After a slow start to the year, we are encouraged by results secured in Q2 against a challenging market backdrop...As we head into our busiest sales period at a consumer level, we’ve been working with our UK distributor to ensure that our promotional offering is compelling, and in addition are already putting plans in place to secure strong activity for 2026.’ Also says Distil hopes ‘no further hardships are imposed on the industry in terms of duty increases’ by the Autumn Budget, and notes ‘indicators that consumer confidence is slowly rebuilding’. ---------- ImmuPharma PLC - London-based specialist drug discovery and development company - Announces the launch of its new corporate website, which marks ‘another step in the Company’s scientific and corporate evolution and placing its proprietary P140 autoimmune platform at the forefront of its strategy’. Also says it is engaging with a number of potential partners, having filed ‘a new groundbreaking P140 patent’ as announced in September. Furthermore, ImmuPharma has recently extended its cash runway into the second half of 2026 through ‘the exercise of warrants and enhanced monthly cash receipts under the current Lanstead Capital sharing agreement’. Company does not intend to conduct further fundraising and plans to further strengthen its cash position through deals with potential partners. ---------- Newmark Security PLC - London-based security and workforce management firm transitioning to subscription-based sales - Chair Maurice Dwek, at the company’s annual general meeting on Thursday morning, says Newmark is ‘on track to deliver strong H1 results, marked by sales growth and improved profitability’ and remains ‘positive about the outlook for the rest of the year’, noting that the firm is historically second half-weighted. Also comments: ‘Newmark has been transformed in recent years with Human Capital Management (HCM) now at the forefront of our growth. We have developed partnerships with major software houses in Europe and North America and our products are being adopted by new users and displacing competitors.’ Adds that he is ‘pleased to confirm that Safetell’s strategic review is advancing’ and that ‘With sales up and previously delayed contracts being fulfilled, the business is in a stronger position for the future.’ Newmark also intends to appoint two new independent non-executive directors to the board, based on ‘the need for an appropriate balance of independence and skills to deliver for all our stakeholders’. Later, Newmark reports that at the AGM most resolutions were passed except resolution 6 which received 53.57% of votes in favour. This was ‘a special resolution concerning the disapplication of pre-emption rights for the issuance of new ordinary shares’. Resolution 5 passed with 58.52%. ---------- Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
